| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |